FDA approves weight loss drug Zepbound for sleep apnea - NBC News
Dec 20, 2024 · Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said. It's the first medication for the disorder, which affects about 39...
FDA Approves First Medication for Obstructive Sleep Apnea
Dec 20, 2024 · Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in...
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
Dec 20, 2024 · For people with obstructive sleep apnea, Zepbound should be used with a reduced-calorie diet and increased physical activity, drugmaker Eli Lilly said. The US Food and Drug Administration on...
FDA approves weight-loss drug Zepbound to treat sleep apnea
2 days ago · The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, making it the ...
FDA approves weight loss drug Zepbound to treat sleep apnea : …
Dec 21, 2024 · The Food and Drug Administration on Friday authorized the use of Zepbound, made by Eli Lilly & Co., for adults with obesity and moderate to severe obstructive sleep apnea (OSA), a common...
FDA Approves Zepbound for Obstructive Sleep Apnea - WebMD
Dec 23, 2024 · Results showed that Zepbound significantly reduced breathing interruptions (apnea and hypopnea) during sleep compared to the placebo. More patients treated with Zepbound saw their symptoms...
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea - U.S. News …
MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the...
Zepbound approved for sleep apnea - USA TODAY
Dec 20, 2024 · The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...
FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea ...
Dec 20, 2024 · The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity -- the first medication approved for the condition.
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea ...
Dec 20, 2024 · The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep apnea, which refers to breathing interrupted...